Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Summary

LipidBrick® IM21.7c cationic lipids offer new possibilities in LNP engineering for RNA therapeutics and its Impact of a novel cationic lipid on both mRNA, LNP properties and in vivo biodistribution.

In this webinar Dr. Malik Hellal , Dr. Claire Guéguen and Dr. Julien Dépollier will present how Polyplus developed LipidBrick® IM21.7c to overcome current limitations of ionizable lipids by enabling a wider in vivo biodistribution and decreasing accumulation in the liver. LipidBrick® IM21.7c aims to to improve LNP formulation to meet the growing demand of the mRNA therapeutic market.

Learn more about how novel cationic lipid can address current challenges for mRNA therapeutics:

  • Improves efficiency of LNPs
  • Improves biodistribution of LNPs to broaden their use
  • Ensures drug and patient safety with improved particle stability
Learn more

Resources

Articles

An Overview of RNA Delivery: challenges and innovation

Webinars

Webinar replay : Cationic lipids offer new possibilities in liposome and LNP engineering for RNA therapeutics

Events

Bioprocessing Summit Europe 2023

Visuals

Expert podcast: Supporting COVID-19 vaccine strategies

Pressroom

Polyplus Announces GMP Accreditation for DNA Production at Xpress Biologics Belgian Facility

View All Resources